NVNO (enVVeno Medical) Cyclically Adjusted Book per Share: $-24.22 (As of Mar. 2026)


NVNO enVVeno Medical Corp NVNO
26 GF Score
Price $11.10
! 3 Warning Signs
View Full Analysis

What is enVVeno Medical Cyclically Adjusted Book per Share?

enVVeno Medical NVNO -0.09% 26 Cyclically Adjusted Book per Share is $-24.22 as of Mar. 2026. GuruFocus rates NVNO with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

enVVeno Medical's adjusted book value per share for the three months ended in Mar. 2026 was $36.200. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-24.22 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-06), enVVeno Medical's current stock price is $11.1001. enVVeno Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $-24.22. enVVeno Medical's Cyclically Adjusted PB Ratio of today is .


enVVeno Medical  (NAS:NVNO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


enVVeno Medical Cyclically Adjusted Book per Share Related Terms


enVVeno Medical Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for enVVeno Medical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

enVVeno Medical Cyclically Adjusted Book per Share Chart

enVVeno Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

enVVeno Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -24.22

NVNO vs STME, TRIB, AIDX: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, enVVeno Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


enVVeno Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, enVVeno Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where enVVeno Medical's Cyclically Adjusted PB Ratio falls into.


NVNO
26GF Score
enVVeno Medical Corp NVNO
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

enVVeno Medical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, enVVeno Medical's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=36.2/330.2130*330.2130
=36.200

Current CPI (Mar. 2026) = 330.2130.

enVVeno Medical Quarterly Data

Book Value per Share CPI Adj_Book
201512 -325.182 236.525 -453.987
201609 0.000 241.428 0.000
201612 -383.545 241.432 -524.585
201703 0.000 243.801 0.000
201706 -577.909 244.955 -779.054
201709 -741.909 246.819 -992.582
201712 -1,011.909 246.524 -1,355.428
201803 -1,311.750 249.554 -1,735.724
201806 354.692 251.989 464.798
201809 272.462 252.439 356.405
201812 156.615 251.233 205.850
201903 179.063 254.202 232.606
201906 232.600 256.143 299.862
201909 154.200 256.759 198.314
201912 49.500 256.974 63.608
202003 -0.682 258.115 -0.872
202006 13.667 257.797 17.506
202009 104.239 260.280 132.246
202012 97.233 260.474 123.266
202103 177.004 264.877 220.665
202106 168.206 271.696 204.434
202109 214.221 274.310 257.878
202112 200.753 278.802 237.772
202203 189.362 287.504 217.492
202206 171.801 296.311 191.457
202209 157.458 296.808 175.180
202212 142.911 296.797 159.001
202303 125.937 301.836 137.777
202306 106.317 305.109 115.065
202309 91.937 307.789 98.635
202312 121.579 306.746 130.880
202403 111.205 312.332 117.571
202406 100.835 314.175 105.982
202409 94.551 315.301 99.023
202412 84.150 315.605 88.045
202503 76.461 319.799 78.951
202506 60.104 322.561 61.530
202509 50.946 324.800 51.795
202512 41.357 324.054 42.143
202603 36.200 330.213 36.200

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-24.22 mean?
enVVeno Medical (NVNO) has a Cyclically Adjusted Book per Share of $-24.22 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on enVVeno Medical and its competitors.
Is enVVeno Medical's Cyclically Adjusted Book per Share too high?
enVVeno Medical's current Cyclically Adjusted Book per Share is $-24.22. Overall, enVVeno Medical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does enVVeno Medical's Cyclically Adjusted Book per Share compare to STME and TRIB?
enVVeno Medical's Cyclically Adjusted Book per Share of $-24.22 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on enVVeno Medical and its competitors. enVVeno Medical's current Cyclically Adjusted Book per Share is $-24.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is enVVeno Medical stock overvalued right now?
enVVeno Medical (NVNO) has a current Cyclically Adjusted Book per Share of $-24.22. The current Cyclically Adjusted Book per Share is $-24.22. enVVeno Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For enVVeno Medical (NVNO), the current Cyclically Adjusted Book per Share is $-24.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

enVVeno Medical Business Description

Address 70 Doppler, Irvine, CA, USA, 92618
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
26GF Score

Get the complete analysis for NVNO

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.10
Price